Biotech IPOs have set records for the last two years and upcoming inventory is looking strong.
@Nasdaq Head of Healthcare Listings Jordan Saxe (@saxamillion) speaks with @WSJ about biotechs planning to go public over the next 12-to-18 months.Read more: https://t.co/Yy6UuM6Q5z
— Nasdaq (@Nasdaq) April 10, 2022
Source: Twitter
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.